ImpactRx is a biotechnology and healthcare startup that was founded in 2000. The company's proprietary methodology involves a longitudinal panel of high-value, smartphone-connected physicians, making it the exclusive source of continuously captured promotion and treatment data. Annually capturing one million details and three million treatment decisions, the company leverages this data to fuel its unique ImpactData.
With its headquarter located in Mount Laurel, New Jersey, ImpactRx received a significant $1.20M Series E investment on 11 January 2010. The investment came from a group of notable investors including Omega Funds, Oxford Bioscience Partners, Mediphase Venture Partners, and Merck Capital Ventures.
The startup focuses on offering insightful solutions to pharmaceutical marketing and sales decision-makers by leveraging custom research and analytics, utilizing its unprecedented intelligence. As the company continues to evolve within the biotechnology, health care, health and wellness, and pharmaceutical industries, its ability to continuously capture and analyze data positions it as a key player in the field.
